Why Cell-Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and Infection

PURPOSE OF REVIEW: Although there has been improvement in short-term clinical outcomes for patients following lung transplant (LT), advances have not translated into longer-term allograft survival. Furthermore, invasive biopsies are still standard of practice for monitoring LT recipients for allogra...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenheck, J.P., Keller, B.C., Fehringer, G., Demko, Z.P., Bohrade, S.M., Ross, D.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Lung Transplant (R Bag, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315332/
https://www.ncbi.nlm.nih.gov/pubmed/35910533
http://dx.doi.org/10.1007/s13665-022-00292-8

Ejemplares similares

Ejemplares similares